Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Lawlor Sally Bridget — Quoin Pharmaceuticals, Ltd. insider: 2 transactions · InsiderLens

Home / Insiders / Lawlor Sally Bridget

Lawlor Sally Bridget

Chief Financial Officer at Quoin Pharmaceuticals, Ltd. · on record since Sep 8, 2025

Insider trading activity of Lawlor Sally Bridget

Transactions on record: 2; since Dec 3, 2025

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Feb 6, 2026

Figures computed from official regulatory filings — methodology.

Companies where Lawlor Sally Bridget has traded

Quoin Pharmaceuticals, Ltd.2 tx · Feb 6, 2026

Track record of Lawlor Sally Bridget

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Lawlor Sally Bridget

Co-insiders of Lawlor Sally Bridget

Carter Denise P.Quoin Pharmaceuticals, Ltd.
Cooper Joseph PatrickQuoin Pharmaceuticals, Ltd.
Culverwell Anthony JamesQuoin Pharmaceuticals, Ltd.
Dunn GordonQuoin Pharmaceuticals, Ltd.
LANGER DENNISQuoin Pharmaceuticals, Ltd.
Leong Natalie Ee MunQuoin Pharmaceuticals, Ltd.
MYERS MICHAELQuoin Pharmaceuticals, Ltd.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

SEMBER MICHAEL TQuoin Pharmaceuticals, Ltd.

Stonepine Capital Management, LLCQuoin Pharmaceuticals, Ltd.

Company	Filed	Type	Qty	Price	Value · USD	Src
Quoin Pharmaceuticals, Ltd.	Feb 6, 2026	AwardD	85,250	0.00 USD	$0	SEC
Quoin Pharmaceuticals, Ltd.	Dec 3, 2025	AwardD	10,330	0.00 USD	$0	SEC